More Settlements Likely After Purdue Pharma’s $270M Opioid Settlement

OxyContin maker Purdue Pharma LP has reached a landmark $270 million settlement with the state of Oklahoma resolving litigation over damages caused by the spread of highly addictive prescription opioids that have ravaged communities and led to record numbers of overdoses. The settlement is an indication that numerous other lawsuits filed across the U.S. could be moving toward resolution, said trial lawyer Jonathan Novak of Dallas-based Fears Nachawati.

“All of these lawsuits are based on the same documents and similar allegations against these drugmakers,” said Mr. Novak, who represents states, counties and municipalities in opioid litigation. “If Purdue feels it has a high level of exposure, the company is not going to be fighting this case in other courts.”

Mr. Novak previously investigated pharmaceutical companies as a Department of Justice prosecutor. He said that with drug manufacturers now moving to settle, attention is likely to focus on the role distributers and pharmacies played in flooding communities with highly addictive opioid drugs.

To speak with Mr. Novak about opioid litigation, contact Robert Tharp at 214-559-4630 or

Are you ready to get started?